Maze Therapeutics Inc (MAZE)

Feb 08, 2026

IPO Launch: Is Maze Therapeutics Inc forming a bullish divergenceJuly 2025 WrapUp & Consistent Return Investment Signals - baoquankhu1.vn

Feb 08, 2026

Feb 07, 2026

Maze Therapeutics (NASDAQ:MAZE) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat

Feb 07, 2026

Feb 04, 2026

Amy Bachrodt Sells 5,000 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock - MarketBeat

Feb 04, 2026

Feb 04, 2026

Insider Selling: Maze Therapeutics (NASDAQ:MAZE) CMO Sells 15,000 Shares of Stock - MarketBeat

Feb 04, 2026

Feb 04, 2026

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Maze Therapeutics, Inc. (MAZE) - The Globe and Mail

Feb 04, 2026

Feb 04, 2026

Maze Therapeutics Secures New $200 Million Loan Facility - TipRanks

Feb 04, 2026

Feb 04, 2026

Maze Therapeutics Signs Loan and Security Agreement With Hercules Capital - TradingView

Feb 04, 2026

Feb 04, 2026

Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times

Feb 04, 2026

Feb 03, 2026

Maze Therapeutics stock hits all-time high at 47.47 USD By Investing.com - Investing.com Nigeria

Feb 03, 2026

Feb 03, 2026

Maze Therapeutics stock hits all-time high at 47.47 USD - Investing.com

Feb 03, 2026

Feb 03, 2026

Maze Therapeutics (NASDAQ:MAZE) Sets New 12-Month HighShould You Buy? - MarketBeat

Feb 03, 2026

Feb 03, 2026

Maze Therapeutics (NASDAQ:MAZE) Insider Atul Dandekar Sells 7,500 Shares of Stock - Defense World

Feb 03, 2026

Feb 02, 2026

Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock - aol.com

Feb 02, 2026

Feb 02, 2026

Maze Therapeutics (NASDAQ:MAZE) Insider Sells $332,025.00 in Stock - MarketBeat

Feb 02, 2026

Feb 01, 2026

Strs Ohio Decreases Stake in Maze Therapeutics, Inc. $MAZE - MarketBeat

Feb 01, 2026

Feb 01, 2026

Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock - The Motley Fool

Feb 01, 2026

Jan 30, 2026

Maze Therapeutics, Inc. (MAZE): Investor Outlook And 9.88% Potential Upside - DirectorsTalk Interviews

Jan 30, 2026

Jan 28, 2026

Washington University Takes Position in Maze Therapeutics, Inc. $MAZE - MarketBeat

Jan 28, 2026

Jan 28, 2026

Maze Therapeutics stock price target reiterated at $60 by H.C. Wainwright - Investing.com Canada

Jan 28, 2026

Jan 28, 2026

Equities Analysts Set Expectations for MAZE FY2030 Earnings - MarketBeat

Jan 28, 2026

Jan 26, 2026

Maze Therapeutics Rings the Closing Bell - Nasdaq

Jan 26, 2026

Jan 25, 2026

Maze Therapeutics (NASDAQ:MAZE) Raised to "Hold" at Wall Street Zen - MarketBeat

Jan 25, 2026

Jan 24, 2026

Maze Therapeutics, Inc. (NASDAQ:MAZE) Given Average Rating of "Buy" by Analysts - MarketBeat

Jan 24, 2026

Jan 23, 2026

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Strong Buy Ratings Amid Potential 7% Upside - DirectorsTalk Interviews

Jan 23, 2026

Jan 23, 2026

Retail Surge: What’s the fair value of Maze Therapeutics Inc. stockQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - mfd.ru

Jan 23, 2026

Jan 21, 2026

First Week of March 20th Options Trading For Maze Therapeutics (MAZE) - Nasdaq

Jan 21, 2026

Jan 20, 2026

Maze Therapeutics (NASDAQ:MAZE) Reaches New 1-Year HighWhat's Next? - MarketBeat

Jan 20, 2026

Jan 19, 2026

Maze Therapeutics (NASDAQ:MAZE) Price Target Raised to $46.00 - Defense World

Jan 19, 2026

Jan 17, 2026

Maze Therapeutics (NASDAQ:MAZE) Cut to "Sell" at Wall Street Zen - MarketBeat

Jan 17, 2026

Jan 16, 2026

BTIG Research Raises Maze Therapeutics (NASDAQ:MAZE) Price Target to $46.00 - MarketBeat

Jan 16, 2026

Jan 16, 2026

Maze Therapeutics: An Innovative, Nature-Driven Platform (NASDAQ:MAZE) - Seeking Alpha

Jan 16, 2026

Jan 15, 2026

Assessing Maze Therapeutics (MAZE) Valuation After Its Recent Share Price Momentum - Sahm

Jan 15, 2026

Jan 12, 2026

What dividend safety score for Maze Therapeutics Inc. stockInflation Watch & Proven Capital Preservation Tips - Bộ Nội Vụ

Jan 12, 2026

Jan 10, 2026

Gainers Report: How Maze Therapeutics Inc stock valuations compare to rivals2025 Technical Patterns & AI Forecast for Swing Trade Picks - Bộ Nội Vụ

Jan 10, 2026

Jan 10, 2026

How Maze Therapeutics Inc. stock benefits from tech adoptionJuly 2025 Final Week & Risk Managed Investment Entry Signals - Улправда

Jan 10, 2026

Jan 10, 2026

How Maze Therapeutics Inc. stock valuations compare to rivalsStock Surge & Low Risk Profit Maximizing Plans - Улправда

Jan 10, 2026

Jan 09, 2026

Maze Therapeutics (NASDAQ:MAZE) CMO Sells 25,156 Shares - MarketBeat

Jan 09, 2026

Jan 09, 2026

Maze Therapeutics (MAZE) Stock Analysis: Exploring a 21.52% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews

Jan 09, 2026

Jan 08, 2026

Maze Therapeutics Director Makes Major Insider Move With High-Value Stock Sale - TipRanks

Jan 08, 2026

Jan 08, 2026

How rising interest rates impact Maze Therapeutics Inc. stock2025 Sector Review & Daily Momentum Trading Reports - Улправда

Jan 08, 2026

Jan 08, 2026

How Maze Therapeutics Inc. stock reacts to oil pricesJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - Улправда

Jan 08, 2026

Jan 08, 2026

Is Maze Therapeutics Inc. stock trading at a premium valuation2025 Bull vs Bear & Safe Capital Growth Stock Tips - Улправда

Jan 08, 2026

Jan 08, 2026

What sentiment indicators say about Maze Therapeutics Inc. stockQuarterly Profit Summary & Reliable Price Breakout Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Is Maze Therapeutics Inc. stock supported by innovation pipeline2025 Technical Patterns & Expert Approved Trade Ideas - Улправда

Jan 08, 2026

Jan 06, 2026

Insider Selling: Maze Therapeutics (NASDAQ:MAZE) CMO Sells 412 Shares of Stock - MarketBeat

Jan 06, 2026

Jan 05, 2026

Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 05, 2026

Jan 04, 2026

BERNSTEIN HAROLD Insider Trades - Nasdaq

Jan 04, 2026

Jan 04, 2026

Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 4.9% – Here’s Why - Defense World

Jan 04, 2026